Literature DB >> 3752756

Higher risk of lung cancer in chronic obstructive pulmonary disease. A prospective, matched, controlled study.

D M Skillrud, K P Offord, R D Miller.   

Abstract

To assess the risk of lung cancer in patients with chronic obstructive pulmonary disease, we matched, on the basis of age, sex, occupation, and smoking history, 113 persons ("cases") who had a forced expiratory volume in 1 second (FEV1) of 70% or less of predicted normal with 113 control persons who had an FEV1 of 85% or more. All persons were observed from 1973-74 through 1984 for a diagnosis of lung cancer, death from lung cancer, and death from any cause. At entry, subjects had an age range of 45 to 59 years; men numbered 186 and women 40. Histologically proven lung cancer developed in 9 cases and in 2 controls, all men. The rate of development of lung cancer was significantly different in the two groups (p = 0.024): the 10-year cumulative percentage was 8.8% for cases and 2.0% for controls. Overall 10-year survival was estimated to be 74.0% for cases and 91.1% for controls (p less than 0.001).

Entities:  

Mesh:

Year:  1986        PMID: 3752756     DOI: 10.7326/0003-4819-105-4-503

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  104 in total

1.  [What can we do about the scant introduction of spirometry into primary care?].

Authors:  C García Benito; F García Río
Journal:  Aten Primaria       Date:  2004-03-31       Impact factor: 1.137

2.  Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee.

Authors:  Lorcan P McGarvey; Matthias John; Julie A Anderson; Michael Zvarich; Robert A Wise
Journal:  Thorax       Date:  2007-02-20       Impact factor: 9.139

3.  Interleukin 6, but not T helper 2 cytokines, promotes lung carcinogenesis.

Authors:  Cesar E Ochoa; Seyedeh Golsar Mirabolfathinejad; Venado Ana Ruiz; Scott E Evans; Mihai Gagea; Christopher M Evans; Burton F Dickey; Seyed Javad Moghaddam
Journal:  Cancer Prev Res (Phila)       Date:  2010-11-22

Review 4.  Update in lung cancer 2007.

Authors:  Sarita Dubey; Charles A Powell
Journal:  Am J Respir Crit Care Med       Date:  2008-05-01       Impact factor: 21.405

5.  Cigarette smoke exposure impairs dendritic cell maturation and T cell proliferation in thoracic lymph nodes of mice.

Authors:  Clinton S Robbins; Francesca Franco; Majd Mouded; Manuela Cernadas; Steven D Shapiro
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

6.  Association of radiographic emphysema and airflow obstruction with lung cancer.

Authors:  David O Wilson; Joel L Weissfeld; Arzu Balkan; Jeffrey G Schragin; Carl R Fuhrman; Stephen N Fisher; Jonathan Wilson; Joseph K Leader; Jill M Siegfried; Steven D Shapiro; Frank C Sciurba
Journal:  Am J Respir Crit Care Med       Date:  2008-06-19       Impact factor: 21.405

7.  Self-reported prior lung diseases as risk factors for non-small cell lung cancer in Mexican Americans.

Authors:  Michelle K McHugh; Matthew B Schabath; Chung-Han Ho; Mei Liu; Anthony M D'Amelio; Anthony J Greisinger; George L Delclos; Margaret R Spitz; Carol J Etzel
Journal:  J Immigr Minor Health       Date:  2013-10

Review 8.  Lung cancer screening in patients with chronic obstructive pulmonary disease.

Authors:  Jessica Gonzalez; Marta Marín; Pablo Sánchez-Salcedo; Javier J Zulueta
Journal:  Ann Transl Med       Date:  2016-04

Review 9.  Smoking, inflammation and small cell lung cancer: recent developments.

Authors:  Gerhard Hamilton; Barbara Rath
Journal:  Wien Med Wochenschr       Date:  2015-08-20

10.  Prognosis of smokers following resection of pathological stage I non-small-cell lung carcinoma.

Authors:  Noriyoshi Sawabata; Shinichiro Miyoshi; Akihide Matsumura; Mitsunori Ohta; Hajime Maeda; Hirofumi Sueki; Masanobu Hayakawa; Meinoshin Okumura; Yoshiki Sawa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2007-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.